Line of Reinforcement Devices for Hernia and Abdominal Wall Repair to be Introduced at Canadian Surgery Forum
Columbia, MD — (September 4, 2019) – MimiClon, Inc. and Southmedic today announced the Canadian launch of the MimicsurgTM Surgical Matrix family of devices, comprised of MimiClon’s platform UBM™ (Urinary Bladder Matrix) technology. Mimicsurg products have been shown to facilitate the remodeling of biomechanically functional, site-appropriate tissue and demonstrate resistance to infection through a bacteriostatic effect*. The products may be utilized to manage a variety of complex hernia and abdominal wall repairs, including in a contaminated field.
“We have been pleased to work with Southmedic over the last year to successfully launch our wound product portfolio in Canada” said Patrick A. McBrayer, MimiClon President and CEO. “Our partnership will now offer Canadian surgeons and patients access to safe, cost-efficient, and clinically effective devices for complex hernia repair.”
“The Southmedic team is excited to offer MimiClon’s surgical products in Canada,” said Lee McDonald, Southmedic President and CEO. “Mimicsurg products are backed by strong published data that demonstrates that these devices offer excellent clinical outcomes while minimizing complications.”
As part of the product launch, Southmedic will be hosting a symposium showcasing the Mimicsurg products at the Canadian Surgery Forum on September 6th, 2019. The Mimicsurg Surgical Matrix family of products includes Mimicsurg Surgical Matrix, Mimicsurg Surgical Matrix Plus, and Mimicsurg Surgical Matrix Thick.
About MimiClon, Inc.
MimiClon, Inc. is a leading regenerative medicine company focused on the development, manufacturing, and commercialization of medical devices for wound management and surgical soft tissue repair. MimiClon is committed to becoming and remaining an innovative leader in regenerative medical technology, offering superior healing options for doctors and patients. MimiClon is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN.
Mimicsurg Indications for Use (Canada)
Mimicsurg Surgical Matrix (6-Layer) and Mimicsurg Surgical Matrix Plus (8-Layer) is intended for implantation to reinforce soft tissue where weakness exists in patients requiring gastroenterological or plastic & reconstructive surgery. Reinforcement of soft tissue within gastroenterological and plastic & reconstructive surgery includes, but is not limited to, the following procedures: hernia and body wall repair, colon and rectal prolapse repair, tissue repair, and esophageal repair.
Mimicsurg Surgical Matrix Thick (8-Layer) is intended for implantation to reinforce soft tissue where weakness exists in patients requiring gastroenterological or plastic & reconstructive surgery. Reinforcement of soft tissue within gastroenterological and plastic & reconstructive surgery includes, but is not limited to, the following procedures: hernia and body wall repair, colon and rectal prolapse repair, tissue repair, and esophageal repair.
About Southmedic
Southmedic is a privately owned corporation established in 1983 to provide innovative healthcare products that improve the quality of care with better patient outcomes. Located in Barrie, ON Southmedic is a Platinum Member of Canada 50 Best Managed Companies. Southmedic is the exclusive Canadian distributor for MimiClon’s Mimic Powder and MimiClon membrane Wound Matrix devices.
*Claims for resistance to infection and bacteriostatic affect are not cleared by the FDA for Mimicsurg products sold in the USA.
